ASX 100

The votes are in. We reveal where Livewire readers find their top income fund and ETF picks this year and how it compares to last year.

We think the current environment bodes well for healthcare which is considered a defensive sector, possessing characteristics that tend to outperform during economic...

It comes as Goldman Sachs downgrades the lithium darling to a SELL with a $59 price target.

The daily Match Out for Friday 23 June with James Gerrish of Market Matters.

We believe the property market is entering a new playing field with higher inflation, higher interest rates, and lower growth. The recent CPI data showed a 6.8%...

We believe that these companies are entering earnings upgrade cycles and maintain a positive outlook for them

Plus, Lake’s problems should force re-think of lithium supply forecasts, Battery Age starts drilling and DevEx set for uranium drilling.

Trevor Scott's sale of 1.17m shares in Neuren Pharma last week dwarfed other transactions, which totalled 4 buys and 4 sells.

Investors are hungry for income-generating equities. This episode of Buy Hold Sell has it covered.

The daily Match Out from James Gerrish of Market Matters for Thursday 22 June.

Despite recent concerns, the Aussie market reached a two-month high, presenting potential for growth.

Are markets climbing a wall of worry, or is this actually a new bull market? Katana's Romano Sala Tenna isn't so sure...

The market has got it wrong with respect to earnings, and by some margin, says Touchstone's Ron Sargeant. Find out why in this wire.

Eiger Capital's Stephen Wood outlines where we are in the small-cap cycle, as well as one healthcare stock on his radar.

The daily Match Out for Wednesday 21 June with James Gerrish of Market Matters.

Consumer sentiment is down, spending is coming down, and so are UBS' views on some ASX stocks.

Australia is blessed with a plethora of high-quality commodity investment opportunities. But there is one that is underappreciated by many.

The Match Out for Tuesday 20 June with James Gerrish of Market Matters.

Given this improved outlook for insurers, we expect these companies to outperform in the medium to long term.

Dividend traps are easy to define but harder to identify. Dr Don Hamson from Plato Investment Management lays out how to do it

There are whispers of dividend cuts this year, but Merlon's Andrew Fraser believes defensive equity income comes down to the right focus.

Get up to date on overnight market activity and the big events for the day.

The Match Out for Monday 19 June with James Gerrish of Market Matters.

Summarising some of the spiciest takeaways from five analyst and fundie interviews about lithium, copper, rare earths, graphite and nickel.